17-19 Chemin du Champ d'Anier
Geneva, Geneva 1211
Switzerland
South Centre
Access to Medicines, Appellate Body, Canada, Dispute Settlement, Doha Declaration on the TRIPS Agreement and Public Health, Flexibilities, Health, India, Intellectual Property, Patent, Pharmaceuticals, Public Health, TRIPS, TRIPS Flexibilities, TRIPS Plus, World Trade Organization (WTO), WTO Panel
Access and Benefit-Sharing (ABS), Convention on Biological Diversity (CBD), Disclosure, Food and Agriculture Organization (FAO), Free Trade Agreements (FTAs), Genetic Resources, Genetic Sequence Data (GSD), Genetic Sequence Information (GSI), Intellectual Property, Intellectual Property Rights (IPRs
Access to Medicines, COVID-19, Customary International Law, Free Trade Agreements (FTAs), Health, Health Technologies, Intellectual Property, Intellectual Property Rights (IPRs), International Law, Investment Agreement, Investment Treaties, Investor-State Dispute Settlement (ISDS) System, Moratorium
COVID-19, pandemic, TRIPS waiver, public health flexibilities, diagnostics, therapeutics
Berne Convention, Capacity Building, Committee on Development and Intellectual Property (CDIP), Competition Law, Compulsory Licenses, Development Agenda Group (DAG), Flexibilities, Innovation, Intellectual Property, Intellectual Property (IP) Enforcement, Least Developed Countries (LDCs), Paris Conv
COVID-19, Pandemic, TRIPS Waiver, Public Health Flexibilities, Diagnostics, Therapeutics
